08:08 AM EDT, 06/26/2024 (MT Newswires) -- Intellia Therapeutics ( NTLA ) said Wednesday it has named Edward Dulac its chief financial officer, effective July 22.
Dulac will succeed Glenn Goddard, who is stepping down on Sunday, the company said.
Dulac most recently served as Fate Therapeutics' (FATE) CFO.
Price: 24.35, Change: +0.35, Percent Change: +1.46